Company profilePharmaceutical#918 of 1,318 in Pakistan✓ No DRAP alerts

Leo Pharmaceutical Products

Pharmaceutical company · 5 brands · 3 molecules

Ranked #16 of 58 companies in Skin Conditions

5 registered products 5 pharmaceutical brands 3 distinct molecules 0 DRAP alerts

Company overview

5
registered products
5
pharmaceutical brands
3
distinct molecules
2
therapeutic classes
0
DRAP alerts

Leo Pharmaceutical Products is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 5 product registrations across 3 distinct molecules. Its portfolio is concentrated in Skin Conditions and Antibiotics For Topical Use. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Leo

4 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Therapeutic classes

Skin Conditions · 5Antibiotics For Topical Use · 1

Conditions treated

Eczema/Psoriasis/Dermatitis · 2Infection/Allergy · 2Acne/Topical · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 405.7 – Rs 405.7
Servaid5 products · Rs 356.5 – Rs 1,797.95
Median across source: Rs 444.68

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.2 shared molecules
CRYSTOLITE PHARMACEUTICALS2 shared molecules
VALOR PHARMACEUTICALS2 shared molecules
NEUTRO PHARMA (PVT) LTD.2 shared molecules
LEO/ZAMZAM2 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 137 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
MASS PHARMA (PRIVATE) LIMITED holds 127 molecules not in this portfolio
000 I.UAcitretinAcitretin UspAmikacinAmlodipineAmlodipine Usp
NABIQASIM INDUSTRIES (PVT) LTD. holds 193 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir

Get the full profile for Leo

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.